Electroencephalographic Biomarker to Predict Postoperative Delirium
Key facts
- Who runs it
- University of Chile
- Where
- Chile2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 264 people, planned
- Started
- 1 Sept 2023
- Ended
- 30 Jun 2026
- Type of study
- Observational
- Treatments tested
- POD risk estimation using PEUMA
- Record updated
- 20 November 2025
Who can take part
- Age
- 60 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Age ≥ 60 years old
- Scheduled for high-risk elective surgery
- Need for at least 3 days of hospital stay after surgery
- Surgery performed under general anesthesia
- Written informed consent for participation in the trial
Who cannot take part
- Patients using neuroleptics drug during the past 6 months
- The use of ketamine or dexmedetomidine during surgery
- Emergency surgery
- Mechanical ventilation during the 72 after surgery
- Patients with preoperative delirium or dementia
- Patients with a history of encephalopathy, psychosis, stroke or brain trauma with neurologic sequels
- Analphabetism
- Patients who do not talk Spanish
- Patients included in another clinical trial
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Acute post-operatory cognitive dysfunction states are one of the most important complications in older patients that underwent surgery. Among them postoperative delirium (POD) is the the most studied. Patients who develop delirium have poorer long-term outcomes, such as longer length of hospital stay, institutionalization at discharge, and even higher mortality, and consequently, the human and economic costs significantly increase for the health system. Here the research team will use an observational cohort, investigator blinded in five-center with a primary endpoint to validate intraoperative EEG analysis as a reliable biomarker of postoperative delirium.
The group in the trial
- Patients at risk of developing POD
* Patients older than 60 years * Scheduled for elective surgery of moderate or high risk (defined as that which requires a subsequent hospitalization of at least 3 days) under general anesthesia. * Signed informed consent.
Treatment: POD risk estimation using PEUMA
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Electroencephalographic Biomarker to Predict the Development of Postoperative Delirium: a Protocol of an Observational Study in a Cohort of Patients From Five Centers
- Record updated
- 20 November 2025